ArticleScientific reports2026
A comparative anti-proliferative and immunomodulatory analysis in wild and lab-acclimatized seaweed extracts unravel the functional biopotentials of Acrosiphonia orientalis.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Comparative Metabolite Profiling and Antiproliferative Characterization of Lab-Acclimatized and Wild Green SeaweedFoods (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Marine green algae undergo substantial metabolic shifts during laboratory culture, yet the underlying biochemical mechanisms remain poorly understood. This study aimed to investigate the green seaweed Acrosiphonia orientalis’s multi-approach anti-proliferative and immunomodulatory activities by comparing extracts from laboratory-acclimatized (LabAO) and wild-harvested (WildAO) seaweed samples against human colorectal carcinoma (HCT-116) cell line. Higher accumulation of stress-response metabolites, including phytol, protocatechuic acid, neophytadiene, DHA, and EPA was observed in wild type extract (WildAO). In contrast, extract of lab-acclimatized biomass (LabAO) showed higher accumulation of storage metabolites like trehalose, maltose, and monoolein, as well as essential amino acids such as phenylalanine and isoleucine. Specifically, LabAO had more total sugars, phenolics, chlorophyll, and carotenoids, while WildAO had a higher concentration of flavonoids and proteins. Cancer-linked gene expression analysis revealed that both extracts triggered apoptosis as elevated PRKAA1 and IRS1 gene expression while suppressed SLC2A2 expression, leading to starved cells for energy. Further, GPX1 and SOD2 gene expression declined supporting oxidative stress. High expression of CASP3, TP53 and NDRG1 gene expression showed that cells pushed toward programmed death. Interestingly, expression pattern of NFKB1, MYC and BCL2 showed immunomodulatory activity. These findings highlight the potential of anti-proliferative and immunomodulatory activity, which may further explore for pharmaceuticals and nutraceuticals.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.